. 2018 Feb;18(2):171–179. doi: 10.1016/S1473-3099(17)30654-0

Table 2.

Post-primary and post-booster serotype specific immunoglobulin G geometric mean concentrations in μg/mL

	Post-primary group 1 (2 m, 4 m; N_max=97)^*	Post-primary group 2 (3 m; N_max=102)^*	p value^†	Post-boost group 1 (2 m, 4 m, 12 m; N_max=91)^*	Post-boost group 2 (3 m, 12 m; N_max=86)^*	Group 2 to group 1 ratio^‡	Adjusted^‡p value
1	1·25 (1·07–1·45)	0·57 (0·47–0·69)	<0·0001	3·07 (2·58–3·64)	8·92 (7·42–10·73)	2·73 (2·13–3·51)	<0·0001
3	0·28 (0·23–0·33)	0·27 (0·21–0·34)	0·66	0·61 (0·51–0·74)	0·62 (0·52–0·74)	0·93 (0·72–1·19)	0·57
4	1·08 (0·93–1·26)	0·43 (0·36–0·51)	<0·0001	2·55 (2·15–3·04)	3·43 (2·86–4·12)	1·29 (1·01–1·64)	0·047
5	0·90 (0·77–1·07)	0·29 (0·24–0·35)	<0·0001	1·74 (1·49–2·03)	2·11 (1·81–2·45)	1·15 (0·93–1·42)	0·20
6A	1·25 (1·00–1·56)	0·13 (0·11–0·15)	<0·0001	8·62 (7·29–10·21)	6·36 (5·34–7·58)	0·69 (0·54–0·87)	0·002
6B	0·26 (0·20–0·33)	0·09 (0·08–0·09)	<0·0001	6·19 (5·10–7·50)	2·39 (1·94–2·94)	0·36 (0·27–0·47)	<0·0001
7F	2·46 (2·11–2·88)	0·81 (0·69–0·95)	<0·0001	3·98 (3·42–4·62)	3·36 (2·93–3·86)	0·82 (0·67–1·01)	0·059
9V	0·73 (0·60–0·89)	0·18 (0·16–0·21)	<0·0001	2·34 (2·00–2·73)	2·50 (2·16–2·88)	1·02 (0·83–1·26)	0·85
14	4·19 (3·23–5·43)	1·13 (0·90–1·40)	<0·0001	10·49 (8·84–12·44)	16·9 (13·54–21·08)	1·57 (1·19–2·08)	0·002
18C	0·90 (0·73–1·11)	0·22 (0·19–0·27)	<0·0001	1·98 (1·70–2·30)	1·63 (1·42–1·87)	0·78 (0·64–0·95)	0·017
19A	1·56 (1·25–1·96)	0·33 (0·27–0·39)	<0·0001	8·38 (7·17–9·80)	8·83 (7·4–10·52)	1·00 (0·79–1·26)	0·98
19F	4·54 (3·80–5·42)	0·64 (0·54–0·76)	<0·0001	11·12 (9·46–13·07)	14·76 (12·54–17·37)	1·28 (1·02–1·61)	0·035
23F	0·43 (0·34–0·54)	0·09 (0·08–0·10)	<0·0001	2·87 (2·38–3·46)	1·72 (1·44–2·05)	0·56 (0·44–0·73)	<0·0001

Data are geometric mean (95% CI).

Table 3 shows actual numbers.

^†

Kruskal-Wallis test.

^‡

Adjusted in regression for sex and interval to blood.